Victory Capital Management’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17,480
| Closed | -$627K | – | 2516 |
|
|
2024
Q4 | $627K | Sell |
17,480
-216
| -1% | -$8.08K | ﹤0.01% | 1967 |
|
|
2024
Q3 | $671K | Sell |
17,696
-614
| -3% | -$25.2K | ﹤0.01% | 1929 |
|
|
2024
Q2 | $828K | Sell |
18,310
-6,630
| -27% | -$305K | ﹤0.01% | 1785 |
|
|
2024
Q1 | $1.21M | Sell |
24,940
-1,346
| -5% | -$65.9K | ﹤0.01% | 1649 |
|
|
2023
Q4 | $1.41M | Sell |
26,286
-78
| -0.3% | -$3.94K | ﹤0.01% | 1558 |
|
|
2023
Q3 | $1.55M | Buy |
26,364
+1,169
| +5% | +$73.1K | ﹤0.01% | 1469 |
|
|
2023
Q2 | $1.59M | Sell |
25,195
-3,085
| -11% | -$196K | ﹤0.01% | 1471 |
|
|
2023
Q1 | $1.78M | Sell |
28,280
-1,801
| -6% | -$107K | ﹤0.01% | 1444 |
|
|
2022
Q4 | $1.6M | Buy |
30,081
+13,539
| +82% | +$733K | ﹤0.01% | 1515 |
|
|
2022
Q3 | $927K | Buy |
16,542
+420
| +3% | +$27.8K | ﹤0.01% | 1771 |
|
|
2022
Q2 | $1.17M | Buy |
16,122
+8,039
| +99% | +$599K | ﹤0.01% | 1672 |
|
|
2022
Q1 | $620K | Buy |
8,083
+2,840
| +54% | +$256K | ﹤0.01% | 2041 |
|
|
2021
Q4 | $531K | Sell |
5,243
-89
| -2% | -$8.88K | ﹤0.01% | 2121 |
|
|
2021
Q3 | $492K | Buy |
5,332
+249
| +5% | +$24K | ﹤0.01% | 2183 |
|
|
2021
Q2 | $521K | Buy |
5,083
+463
| +10% | +$46.5K | ﹤0.01% | 2187 |
|
|
2021
Q1 | $451K | Buy |
4,620
+583
| +14% | +$53.1K | ﹤0.01% | 2249 |
|
|
2020
Q4 | $311K | Buy |
4,037
+274
| +7% | +$21.2K | ﹤0.01% | 2273 |
|
|
2020
Q3 | $277K | Buy |
3,763
+266
| +8% | +$21.3K | ﹤0.01% | 2186 |
|
|
2020
Q2 | $257K | Sell |
3,497
-2,761
| -44% | -$217K | ﹤0.01% | 2226 |
|
|
2020
Q1 | $362K | Buy |
6,258
+2,082
| +50% | +$145K | ﹤0.01% | 2194 |
|
|
2019
Q4 | $328K | Buy |
4,176
+718
| +21% | +$52.9K | ﹤0.01% | 2177 |
|
|
2019
Q3 | $236K | Buy |
3,458
+2,292
| +197% | +$154K | ﹤0.01% | 2165 |
|
|
2019
Q2 | $93K | Sell |
1,166
-2,032
| -64% | -$161K | ﹤0.01% | 1642 |
|
|
2019
Q1 | $268K | Buy |
+3,198
| New | +$334K | ﹤0.01% | 1488 |
|
|
2018
Q1 | – | Sell |
-2,915
| Closed | -$216K | – | 1926 |
|
|
2017
Q4 | $216K | Buy |
2,915
+253
| +10% | +$16.9K | ﹤0.01% | 1539 |
|
|
2017
Q3 | $154K | Buy |
2,662
+172
| +7% | +$10.2K | ﹤0.01% | 1626 |
|
|
2017
Q2 | $160K | Buy |
2,490
+373
| +18% | +$23K | ﹤0.01% | 1554 |
|
|
2017
Q1 | $122K | Buy |
2,117
+1,175
| +125% | +$70.1K | ﹤0.01% | 1585 |
|
|
2016
Q4 | $58K | Sell |
942
-24
| -2% | -$1.56K | ﹤0.01% | 1696 |
|
|
2016
Q3 | $67K | Buy |
966
+264
| +38% | +$17.4K | ﹤0.01% | 1663 |
|
|
2016
Q2 | $39K | Buy |
702
+308
| +78% | +$18.6K | ﹤0.01% | 1561 |
|
|
2016
Q1 | $24K | Sell |
394
-210
| -35% | -$12.4K | ﹤0.01% | 1602 |
|
|
2015
Q4 | $39K | Sell |
604
-18
| -3% | -$1.17K | ﹤0.01% | 1598 |
|
|
2015
Q3 | $42K | Sell |
622
-512
| -45% | -$36.2K | ﹤0.01% | 1533 |
|
|
2015
Q2 | $79K | Buy |
+1,134
| New | +$72K | ﹤0.01% | 1316 |
|
Other funds holding USNA
Victory Capital Management's USNA Position: Q1 2025 in Review
Victory Capital Management sold out of Usana Health Sciences (USNA) in Q1 2025, closing a stake of 17,480 shares — an estimated $627K sold.
Victory Capital Management first reported a position in USNA in Q2 2015 and held it in 35 quarters. The position peaked at $1.78M in Q1 2023. 162 funds tracked by Wall St. Rank hold USNA as of Q1 2025.
- Victory Capital Management reported no remaining Usana Health Sciences position as of Q1 2025 after selling out during the quarter.
- Victory Capital Management sold 17,480 Usana Health Sciences shares in Q1 2025, an estimated $627K.
- Victory Capital Management first reported a position in Usana Health Sciences in Q2 2015 and held it in 35 quarters.
- Victory Capital Management's Usana Health Sciences position peaked at $1.78M in Q1 2023.
- 162 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2025.
Based on Victory Capital Management's 13F filing for Q1 2025, filed 2 May 2025.